NuCana (NCNA)
(Delayed Data from NSDQ)
$3.84 USD
-0.16 (-4.00%)
Updated Apr 24, 2024 03:52 PM ET
3-Hold of 5 3
D Value B Growth D Momentum D VGM
Income Statements
Fiscal Year end for NuCana PLC Sponsored ADR falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 39 | 54 | 66 | 42 | 33 |
Income After Depreciation & Amortization | -39 | -54 | -66 | -42 | -33 |
Non-Operating Income | -1 | 7 | 1 | -4 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -40 | -48 | -66 | -46 | -33 |
Income Taxes | -5 | -8 | -10 | -7 | -5 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -34 | -40 | -56 | -39 | -27 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -34 | -40 | -56 | -39 | -27 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -39 | -54 | -65 | -41 | -32 |
Depreciation & Amortization (Cash Flow) | 1 | 1 | 1 | 1 | 1 |
Income After Depreciation & Amortization | -39 | -54 | -66 | -42 | -33 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 2.09 | 2.10 | 2.08 | 1.52 | 1.30 |
Diluted EPS Before Non-Recurring Items | -16.50 | -18.75 | -26.75 | -26.00 | -21.00 |
Diluted Net EPS (GAAP) | -16.48 | -18.86 | -26.83 | -26.00 | -21.07 |
Fiscal Year end for NuCana PLC Sponsored ADR falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 10.13 | 11.16 | 7.16 | 10.27 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -10.13 | -11.16 | -7.16 | -10.27 |
Non-Operating Income | NA | -0.42 | 0.90 | -0.48 | -0.50 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -11.19 | -10.25 | -7.64 | -10.76 |
Income Taxes | NA | -1.63 | -1.78 | -0.86 | -1.21 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -9.56 | -8.48 | -6.78 | -9.56 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -9.56 | -8.48 | -6.78 | -9.56 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 2.19 | 2.06 | 2.17 | 2.10 |
Diluted EPS Before Non-Recurring Items | NA | -4.25 | -4.00 | -3.25 | -4.50 |
Diluted Net EPS (GAAP) | NA | -4.68 | -4.11 | -3.13 | -4.56 |